Amongst human healthcare products, vaccines occupy a uniquely special place thanks to their critically essential nature, the seasonality of some of the diseases they treat, their biological composition and their somewhat commodity- like status The following PDF provides an overview of vaccine naming strategies. Vaccines Naming To contact Purple Fire Branding, specialists in brand naming, […]
66 positive opinions were issued by the EMA for authorisation of drugs and medicinal treatments in 2019. The following PDF provides an overview of the EMA name recommendations in 2019. PFB EMA Brand name recommendations – 2019 To contact Purple Fire Branding, specialists in brand naming, research and design, please telephone +44 (0)20 8166 […]
Last year saw the FDA approve no less than 48 new molecular entities and new therapeutic biological products, so-called “novel drug”.. The following PDF provides an overview of the FDA name approvals in 2019. PFB, FDA Brand name approvals -2019 To contact Purple Fire Branding, specialists in brand naming, research and design, please […]
Biologic therapies and cancer agents abounded among the most recent proposed International Nonproprietary Names (INN) list published by the World Health Organization. The following PDF provides an overview of the trends in 2019. INN_Trends_2019 INN Trends 2019 To contact Purple Fire Branding, specialists in brand naming, research and design, please […]
FDA and EMA 2018 approvals: Pharmaceutical product naming in the US and Europe is characterized by the broad array of different name types in use, ranging from the more identifiably suggestive to the outright arbitrary. The following PDF outlines a number of trends in name type approvals by both agencies in 2018. PFB, […]
To those outside the healthcare marketing world, or the niche pharmaceutical naming industry, the rationale behind many Rx drug brand names can appear either quite mystifying or, indeed, wholly absent. However, there are irresistible forces, and regulations, at work that have forged the current ‘namescape’ when it comes to prescription drug names in particular. Successful […]
To follow a few previous more general thoughts on the “art and science” of pharmaceutical product name development, here is a briefer examination of a couple of recent style trends in oncology and elsewhere, as well as some notable differences in regional trademark registration approaches and strategies to enhance Rx (pre)scriptability/legibility. Mechanical action In […]
“You are what you eat” – so say the dieticians. Put another way, we are what we consume, and as consumers the brands we chose to buy can say a lot about our personalities. What does the purchase of an Apple i-Pad/Pod/Phone say about its user and how does wearing Gucci/Prada/Armani reflect upon the personality […]
Branding in the animal health marketplace presents its own very unique challenges and differs from human health product marketing in some quite distinct and particular ways. There are of course many overlapping features between the animal and human health worlds – safety issues, clarity of labelling and prescribing protocols, ease of recognition and need for […]
In today’s world of near-instant digital interconnectedness and heightened awareness, “glocalisation” truly has become the creed by which all businesses need to abide by. However, there are but a few communication tools that function better as a universal lingua franca than multi-market brands, and their accompanying names. Brand names are the true globe-trotting, “one market” […]